Back to Search
MARJAN SARAH KHAZAELI PHARM.D., BCACP
PHARM.D., BCACP
Pharmacist
NPI: 1861834871Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
121326(MN)
Research & Publications (20)
Role of postcircumcision mucosal cuff length in lifelong premature ejaculation: a pilot study.
PMID 17451487·J Sex Med·2008
4-observational
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
PMID 16877732·J Clin Oncol·2006
3-trial
Use of Surgicel for sealing nephrostomy tract after totally tubeless percutaneous nephrolithotomy.
PMID 16724896·J Endourol·2006
2-rct
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
PMID 16248766·Cancer Biother Radiopharm·2005
7-preclinical
Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.
PMID 15778575·Cancer Biother Radiopharm·2005
3-trial
Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
PMID 15809487·J Nucl Med·2005
3-trial
Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion protein.
PMID 15778590·Cancer Biother Radiopharm·2005
8-other
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
PMID 16299250·Clin Cancer Res·2005
7-preclinical
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
PMID 16248762·Cancer Biother Radiopharm·2005
3-trial
Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
PMID 15690125·J Neurooncol·2005
7-preclinical
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
PMID 16114986·Cancer Biother Radiopharm·2005
3-trial
Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
PMID 15585383·J Gastrointest Surg·2004
7-preclinical
Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma.
PMID 14761924·Ann Surg Oncol·2004
8-other
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas.
PMID 15569986·Clin Cancer Res·2004
3-trial
Evaluation of human anti-mouse antibody response in normal volunteers following repeated injections of fanolesomab (NeutroSpec), a murine anti-CD15 IgM monoclonal antibody for imaging infection.
PMID 15266175·Nucl Med Commun·2004
3-trial
A novel monoclonal antibody design for radioimmunotherapy.
PMID 14629823·Cancer Biother Radiopharm·2003
3-trial
Development of an HPLC method for simultaneous analysis of five antineoplastic agents.
PMID 12519685·Appl Occup Environ Hyg·2003
8-other
A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents.
PMID 12519686·Appl Occup Environ Hyg·2003
8-other
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
PMID 12684400·Clin Cancer Res·2003
3-trial
Comparison of methods for predicting myelotoxicity for non-marrow targeting I-131-antibody therapy.
PMID 12804046·Cancer Biother Radiopharm·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via FAIRVIEW PHARMACY SERVICES, LLC · 2 locations total
- Address
- 1099 HELMO AVE N STE 100
OAKDALE, MN 55128 - Phone
- (651) 326-5300
Quick Facts
- NPI
- 1861834871
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile